Literature DB >> 9664200

Management of travellers' diarrhoea.

J P Caeiro1, H L DuPont.   

Abstract

The most common health problem encountered in international travellers to topical and subtropical areas is diarrhoea. Even though it is not a life-threatening condition, it may influence deeply the quality of a vacation or the success of a business trip. The majority of cases of travellers' diarrhoea are due to bacterial pathogens, but viruses have also been implicated in a minority of patients. It is advocated that travellers with diarrhoea provide themselves with sources of salt (crackers or soup) and mineral water, to prevent and treat dehydration. Otherwise, treatment recommendations follow illness severity. For mild cases, symptomatic relief alone can be recommended. Loperamide is an effective agent improving diarrhoea and associated symptoms. For moderate diarrhoea (requiring a forced change in itinerary) combination therapy is advised using a fluoroquinolone together with loperamide. Severe diarrhoea [fever > 38 degrees C, dysentery (bloody stools) or incapacitating symptoms] should prompt the voyager to take an antibiotic alone for 3 to 5 days. Loperamide is relatively contraindicated in these cases. For the minority of patients receiving chemoprophylaxis to prevent travellers' diarrhoea, fluoroquinolones taken once a day while in the area at risk produce the highest protection rate (up to 95%). However, most authorities do not recommend routine prophylaxis for travellers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9664200     DOI: 10.2165/00003495-199856010-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  37 in total

1.  'Boil it, cook it, peel it or forget it': does this rule prevent travellers' diarrhoea?

Authors:  M Kozicki; R Steffen; M Schär
Journal:  Int J Epidemiol       Date:  1985-03       Impact factor: 7.196

2.  Etiology of acute diarrhea among United States military personnel deployed to South America and west Africa.

Authors:  A L Bourgeois; C H Gardiner; S A Thornton; R A Batchelor; D H Burr; J Escamilla; P Echeverria; N R Blacklow; J E Herrmann; K C Hyams
Journal:  Am J Trop Med Hyg       Date:  1993-02       Impact factor: 2.345

3.  Diarrheal disease aboard a U.S. Navy ship after a brief port visit to a high risk area.

Authors:  R L Haberberger; D A Scott; S A Thornton; K C Hyams
Journal:  Mil Med       Date:  1994-06       Impact factor: 1.437

4.  Travelers' diarrhea. NIH Consensus Development Conference.

Authors: 
Journal:  JAMA       Date:  1985-05-10       Impact factor: 56.272

5.  Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults.

Authors:  S J Savarino; F M Brown; E Hall; S Bassily; F Youssef; T Wierzba; L Peruski; N A El-Masry; M Safwat; M Rao; M Jertborn; A M Svennerholm; Y J Lee; J D Clemens
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

6.  Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico.

Authors:  H L DuPont; C D Ericsson; J J Mathewson; F J de la Cabada; D A Conrad
Journal:  JAMA       Date:  1992-04-08       Impact factor: 56.272

Review 7.  Persistent diarrhea in travelers.

Authors:  H L DuPont; E G Capsuto
Journal:  Clin Infect Dis       Date:  1996-01       Impact factor: 9.079

8.  Diarrheal disease during Operation Desert Shield.

Authors:  K C Hyams; A L Bourgeois; B R Merrell; P Rozmajzl; J Escamilla; S A Thornton; G M Wasserman; A Burke; P Echeverria; K Y Green
Journal:  N Engl J Med       Date:  1991-11-14       Impact factor: 91.245

9.  Travelers' diarrhea among United States military personnel during joint American-Egyptian armed forces exercises in Cairo, Egypt.

Authors:  R L Haberberger; I A Mikhail; J P Burans; K C Hyams; J C Glenn; B M Diniega; S Sorgen; N Mansour; N R Blacklow; J N Woody
Journal:  Mil Med       Date:  1991-01       Impact factor: 1.437

10.  Single Dose Ofloxacin plus Loperamide Compared with Single Dose or Three Days of Ofloxacin in the Treatment of Traveler's Diarrhea.

Authors: 
Journal:  J Travel Med       Date:  1997-03-01       Impact factor: 8.490

View more
  4 in total

1.  Medical provision and usage for the 1999 Everest marathon.

Authors:  D G Buckler; F O'Higgins
Journal:  Br J Sports Med       Date:  2000-06       Impact factor: 13.800

Review 2.  Antimicrobial prophylaxis in adults.

Authors:  Mark J Enzler; Elie Berbari; Douglas R Osmon
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

3.  Preparing patients to travel abroad safely. Part 1: Taking a travel history and identifying special risks.

Authors:  R E Thomas
Journal:  Can Fam Physician       Date:  2000-01       Impact factor: 3.275

Review 4.  Rifaximin: a review of its use in the management of traveller's diarrhoea.

Authors:  Gayle W Robins; Keri Wellington
Journal:  Drugs       Date:  2005       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.